How should I obtain and interpret a real‑time PCR test for Bordetella pertussis?

PCR Testing for Pertussis: Specimen Collection and Interpretation

While PCR for Bordetella pertussis offers superior sensitivity (80-100%) compared to culture, the ACCP guidelines explicitly state it should not be used for routine clinical testing because no universally accepted, validated technique exists, though this recommendation conflicts with widespread current practice. 1, 2

Specimen Collection Technique

Obtain a nasopharyngeal specimen using either:

• Nasopharyngeal aspirate, OR
• Dacron (polyester) swab of the posterior nasopharynx 1, 2, 3

Critical collection details:

• Avoid calcium alginate swabs – they inhibit nucleic acid amplification testing 4
• Contact the laboratory beforehand for specific instructions, as B. pertussis is a fastidious pathogen requiring special handling 4
• Collect specimens as early as possible in the illness course (ideally within the first 2-3 weeks of cough onset) when bacterial load is highest 3

Interpreting PCR Results

Performance Characteristics

• Sensitivity: 80-100% (substantially higher than culture's 25-64%) 2, 3, 5
• Specificity: 88-100% 6, 4, 3
• PCR is rapid and highly specific for Bordetella species 2, 3

Cycle Threshold (Ct) Values Matter Clinically

Low Ct values (<30) correlate with:

• More severe disease and hospitalization (median Ct 20.7 in hospitalized vs. 31.6 in non-hospitalized patients) 7
• Higher likelihood of true infection – all patients with IS481 Ct <30 tested positive by confirmatory assays and were clinical pertussis cases 8
• 100% positive predictive value for clinical pertussis 8

High Ct values (≥36 to <40) are "indeterminate":

• These results do not reliably correlate with clinical symptoms 7
• No patients with IS481 Ct ≥40 tested positive by culture 8
• The positive predictive value of PCR overall is only 68% when compared to clinical symptoms 7

Practical interpretation algorithm:

• Ct <30: Treat as confirmed pertussis; culture not needed 8
• Ct 30-40: Consider culture confirmation; interpret in clinical context 8
• Ct ≥40: Likely false positive; do not treat unless strong clinical suspicion 8

Critical Limitations and Pitfalls

Lack of Standardization

The major caveat: PCR assays for pertussis remain non-standardized across laboratories in the United States, with coefficients of variation ranging from 10-28% for the same specimens 1, 2, 3, 9. This means:

• Results are not directly comparable between laboratories
• No FDA-approved universal protocol exists (though one FDA-cleared platform is available) 4, 9
• Different extraction methods, PCR platforms, and assays are used 9

Cross-Reactivity with B. holmesii

• Most assays target IS481, which is present in both B. pertussis (218-238 copies) and B. holmesii (32-65 copies) 9, 10
• B. holmesii can cause similar respiratory symptoms 5, 10
• Mitigation strategy: Use multitarget PCR assays that include pertussis toxin (ptxS1) or IS1001 to differentiate species 8, 9, 5
• In practice, B. holmesii detection has been minimal in most populations studied 5

Clinical Context is Paramount

Never rely on PCR alone. Interpret results alongside:

• Clinical symptoms: Paroxysmal cough, post-tussive vomiting, inspiratory whoop lasting >2 weeks 1, 2, 6
• Age: Younger patients (median 10.8 years) more likely to be truly positive 7
• Vaccination status and timing 7
• Local pertussis prevalence and outbreak status 7
• Duration of symptoms: PCR sensitivity decreases after 3-4 weeks of illness 3

When Culture Remains Superior

Culture is still the gold standard with 100% specificity, though only 64% sensitivity under optimal conditions 3. Consider culture:

• For Ct values between 30-40 to confirm diagnosis 8
• For antimicrobial susceptibility testing (increasingly important given macrolide resistance, especially in strains from China where up to 70-100% are resistant) 11
• For public health surveillance and outbreak investigation 9

Treatment Decisions

Do not wait for PCR confirmation to initiate treatment when clinical suspicion is high – start macrolide antibiotics immediately to reduce transmission and symptom duration, especially within the first 2-3 weeks of illness 2, 3. Early treatment diminishes coughing paroxysms and prevents disease spread, though benefit is limited after the paroxysmal phase begins 2.